A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes
SARS-CoV-2 causing coronavirus disease 2019 (COVID-19) has wreaked havoc during the global pandemic of 2020 infecting millions and leaving over a half million dead. As a new virus, not previously in the human population, but with similarities to other coronaviruses causing severe acute respiratory d...
Saved in:
Main Authors: | Colin D. Funk (Author), Ali Ardakani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
by: Colin D. Funk, et al.
Published: (2020) -
COVID-19 in Children: A Review and Parallels to Other Hyperinflammatory Syndromes
by: Charlotte V. Hobbs, et al.
Published: (2020) -
Drugs for paediatric hyperinflammatory syndromes
by: Kam Lun Hon, et al.
Published: (2022) -
Infection-Triggered Hyperinflammatory Syndromes in Children
by: Martina Rossano, et al.
Published: (2022) -
Treatment of toxic epidermal necrolysis and concurrent COVID-19-associated hyperinflammatory syndrome with systemic corticosteroids and etanercept
by: Rachel Choi, MD, et al.
Published: (2022)